ArticleScience translational medicine2023
Vaccination with
Open access · hybridAbstract read
In one paragraph
Article in Science translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
10.1field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 35 citations in OpenAlex.
- Proteome-wide characterization of Plasmodium vivax antigens using a high-density peptide array.PLoS pathogens · 2026Article
- Malaria serology for surveillance, insights into immunity, and vaccine development.Infection and immunity · 2026Review
- Development of novel Aotus nancymaae non-human primate model for the evaluation of Plasmodium vivax blood stage vaccines and immunoprophylactics.Malaria journal · 2026Article
- Article
- PvDBP gene amplification is associated with functional immune evasion by Plasmodium vivax in vivo.Research square · 2026Article
- A longitudinal study of children identifies antibody Fc-mediated functions and antigen targets of immunity to Plasmodium vivax malaria.Immunity · 2026Article
- Cytokine signatures associated with persistent antibody responses to multipleFrontiers in immunology · 2026Article
- Article
- Article
- A Miniaturized Assay to Evaluate Plasmodium cynomolgi and Plasmodium knowlesi as Models for Prioritizing Plasmodium vivax Vaccine Targets.The Journal of infectious diseases · 2025Article
- Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infection.Nature communications · 2025Article
- mRNA-LNP vaccine encoding theMolecular therapy. Nucleic acids · 2025Article
- A novel micronemal protein MP38 is involved in the invasion of merozoites into erythrocytes.mBio · 2025Article
- PfRH5 vaccine; from the bench to the vial.NPJ vaccines · 2025Review
- Controlled human malaria infection studies: insights into recent advances and key immunological and ethical implementation lessons.Frontiers in immunology · 2025Review
- Malaria vaccines: a new era of prevention and control.Nature reviews. Microbiology · 2024Review
- The PvRBP2b-TfR1 interaction is not essential for reticulocytes invasion by Plasmodium vivax isolates from Cambodia.NPJ vaccines · 2024Article
- Proceedings of the Conference "CMV Vaccine Development-How Close Are We?" (27-28 September 2023).Vaccines · 2024Article
- Development and longevity of naturally acquired antibody and memory B cell responses against Plasmodium vivax infection.PLoS neglected tropical diseases · 2024Review
- Structure-based design of a Plasmodium vivax Duffy-binding protein immunogen focuses the antibody response to functional epitopes.Protein science : a publication of the Protein Society · 2024Article
Corrections and comments
- Update of
Authors and funding
36 authors at 7 institutions in 5 countries.
Mimi M HouDepartment of Biochemistry, University of Oxford, Oxford OX1 3QU, UK.ORCID 0000-0002-8517-9147
Jordan R BarrettDepartment of Biochemistry, University of Oxford, Oxford OX1 3QU, UK.ORCID 0000-0003-0746-1945
Yrene ThemistocleousJenner Institute, University of Oxford, Oxford OX3 7DQ, UK.ORCID 0000-0001-9285-6639
Thomas A RawlinsonJenner Institute, University of Oxford, Oxford OX3 7DQ, UK.
Ababacar DioufLaboratory of Malaria and Vector Research, NIAID/NIH, Rockville, MD 20852, USA.
Francisco J MartinezUnité de Biologie de Plasmodium et Vaccins, Institut Pasteur, Université Paris Cité, 25-28 Rue du Dr Roux, 75015 Paris, France.ORCID 0000-0002-2827-0497
Carolyn M NielsenDepartment of Biochemistry, University of Oxford, Oxford OX1 3QU, UK.ORCID 0000-0002-9033-1318
Amelia M LiasDepartment of Biochemistry, University of Oxford, Oxford OX1 3QU, UK.ORCID 0000-0003-2939-7761
Lloyd D W KingDepartment of Biochemistry, University of Oxford, Oxford OX1 3QU, UK.
Nick J EdwardsJenner Institute, University of Oxford, Oxford OX3 7DQ, UK.ORCID 0000-0002-7030-7839
Nicola M GreenwoodJenner Institute, University of Oxford, Oxford OX3 7DQ, UK.
Lucy KinghamJenner Institute, University of Oxford, Oxford OX3 7DQ, UK.
Ian D PoultonJenner Institute, University of Oxford, Oxford OX3 7DQ, UK.ORCID 0000-0002-6603-8461
Baktash KhozoeeJenner Institute, University of Oxford, Oxford OX3 7DQ, UK.ORCID 0000-0002-2470-3283
Cyndi GohJenner Institute, University of Oxford, Oxford OX3 7DQ, UK.ORCID 0000-0002-2124-3947
Susanne H HodgsonDepartment of Biochemistry, University of Oxford, Oxford OX1 3QU, UK.ORCID 0000-0002-0895-3442
Dylan J Mac LochlainnDepartment of Biochemistry, University of Oxford, Oxford OX1 3QU, UK.ORCID 0000-0001-9181-8112
Jo SalkeldDepartment of Biochemistry, University of Oxford, Oxford OX1 3QU, UK.ORCID 0000-0002-7868-7071
Micheline Guillotte-BlisnickUnité de Biologie de Plasmodium et Vaccins, Institut Pasteur, Université Paris Cité, 25-28 Rue du Dr Roux, 75015 Paris, France.
Christèle HuonUnité de Biologie de Plasmodium et Vaccins, Institut Pasteur, Université Paris Cité, 25-28 Rue du Dr Roux, 75015 Paris, France.ORCID 0000-0002-2798-3911
Franziska MohringDepartment of Infection Biology, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.
Jenny M ReimerNovavax AB, Kungsgatan 109, SE-753 18 Uppsala, Sweden.ORCID 0000-0002-0287-4575
Virander S ChauhanInternational Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.
Paushali MukherjeeMulti Vaccines Development Program (MVDP), New Delhi, India.ORCID 0000-0002-2365-2146
Sumi BiswasJenner Institute, University of Oxford, Oxford OX3 7DQ, UK.
Iona J TaylorJenner Institute, University of Oxford, Oxford OX3 7DQ, UK.ORCID 0000-0002-2287-9488
Alison M LawrieJenner Institute, University of Oxford, Oxford OX3 7DQ, UK.
Jee-Sun ChoDepartment of Biochemistry, University of Oxford, Oxford OX1 3QU, UK.
Fay L NugentJenner Institute, University of Oxford, Oxford OX3 7DQ, UK.ORCID 0000-0001-6312-7293
Carole A LongLaboratory of Malaria and Vector Research, NIAID/NIH, Rockville, MD 20852, USA.ORCID 0000-0002-3835-5443
Robert W MoonDepartment of Infection Biology, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.ORCID 0000-0002-9070-4292
Kazutoyo MiuraLaboratory of Malaria and Vector Research, NIAID/NIH, Rockville, MD 20852, USA.ORCID 0000-0003-4455-2432
Sarah E SilkDepartment of Biochemistry, University of Oxford, Oxford OX1 3QU, UK.ORCID 0000-0003-0563-4814
Chetan E ChitnisUnité de Biologie de Plasmodium et Vaccins, Institut Pasteur, Université Paris Cité, 25-28 Rue du Dr Roux, 75015 Paris, France.ORCID 0000-0002-8773-9865
Angela M MinassianDepartment of Biochemistry, University of Oxford, Oxford OX1 3QU, UK.ORCID 0000-0001-7832-9824
Simon J DraperDepartment of Biochemistry, University of Oxford, Oxford OX1 3QU, UK.ORCID 0000-0002-9415-1357
University of Oxford · GBInstitut Pasteur · FRVector Oncology (United States) · USUniversity of London · GBInternational Centre for Genetic Engineering and Biotechnology · INMulti Vaccines Development Program · INNovavax (Sweden) · SE
Funding
Host Immune Responses to Antigens of Malaria ParasitesZIAAI001020 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI LONG, CAROLE · 2009 to 2025
$13.6MDepartment of HealthMedical Research Council G1100086Medical Research Council MR/M021157/1Wellcome Trust 106917Wellcome Trust 106917/Z/15/ZWellcome Trust 108734/Z/15/ZWellcome Trust 209200Wellcome Trust 209200/Z/17/ZWellcome Trust 212336Wellcome Trust 212336/Z/18/Z
Abstract
There are no licensed vaccines against
Indexed as
MalariaParasitesAnimalsHumansPlasmodium vivaxVaccinationVaccinia virus
Identifiers
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.